Hypertension and menopause

by O. D. Ostroumova, I. V. Goloborodova
Published 2019-09-01

Possibilities of using Fosinopril, an angiotensinconverting enzyme inhibitor, combined with Diltiazem, a non-dihydropyridine calcium antagonist, as first-line therapy in the treatm...

by O. D. Ostroumova, I. V. Goloborodova
Published 2019-04-01

Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue

by O. D. Ostroumova, I. V. Goloborodova
Published 2020-07-01

Drug-Induced Heart Failure (Part 2: Mechanisms of Development, Clinical Signs, Differential Diagnosis, Risk Factors, Treatment and Prevention)

by O. D. Ostroumova, I. V. Goloborodova
Published 2020-06-01

Drug-Induced Heart Failure (Part 1: The Urgency of the Problem, the Prevalence, the Effect of Certain Groups of Drugs on the Risk of Development/Progression Heart Failure)

by O. D. Ostroumova, I. V. Goloborodova
Published 2020-03-01

Cardiovascular risk in type 2 diabetes patients

by O. D. Ostroumova, I. V. Goloborodova, V. М. Fomina
Published 2018-08-01

Anticoagulant therapy in the management of patients with atrial fibrillation from the viewpoint of comorbidities: focus on choice

by O. D. Ostroumova, A. A. Zykova, I. V. Goloborodova, A. I. Kochetkov, G. F. Piksina
Published 2018-04-01

TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS

by O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk
Published 2018-07-01

Stroke prevention in patients with atrial fibrillation and comorbidities

by O D Ostroumova, N Yu Voevodina, T F Guseva, E E Pavleeva, G F Piksina, I V Goloborodova
Published 2018-06-01